Health trends among drug users attending needle exchange programmes in Switzerland (1994-2000)

被引:7
作者
Benninghoff, F. [1 ]
Morency, P. [1 ]
Geense, R. [1 ]
Huissoud, T. [1 ]
Dubois-Arber, F. [1 ]
机构
[1] Univ Lausanne, Inst Social & Prevent Med, UEPP, CH-1005 Lausanne, Switzerland
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2006年 / 18卷 / 04期
关键词
D O I
10.1080/09540120500429018
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
As a part of an assessment of the Swiss drug harm-reduction policy, cross-sectional surveys were conducted in 1994, 1996 and 2000 among attenders of all needle exchange programmes (NEP) in Switzerland to assess changes in specific aspects of their health related to drug use. Data were gathered in each NEP over one week, using a questionnaire completed partly with an interviewer and partly self administered. The questionnaire covered socio-demographic characteristics, drug consumption, risk, prevention behaviour and state of health. Over a 6-year period ( 1994-2000), the average age of NEP attenders rose by 4 years. The prevalence of reported HIV remained fairly stable at around 10%. Reported level of Hepatitis C prevalence was high (59%). Incidence of used injection equipment sharing during the last 6 months was low and stable (9% in 1994, 12% in 2000); however, other forms of risk behaviour linked to intravenous drug use, such as sharing spoons, cotton or water, were more frequently reported. The HIV epidemic among NEP attenders seems to be contained, but this is not the case with Hepatitis C, and more attention should be paid to its prevention.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
[21]   Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City [J].
Howe, CJ ;
Fuller, CM ;
Ompad, DC ;
Galea, S ;
Koblin, B ;
Thomas, D ;
Vlahov, D .
DRUG AND ALCOHOL DEPENDENCE, 2005, 79 (03) :389-395
[22]  
KUBLER D, 1996, 1117 IUMSP
[23]  
Ladewig D, 2001, SWISS MED WKLY, V131, P422
[24]   The impact of harm-reduction-based methadone treatment on mortality among heroin users [J].
Langendam, MW ;
van Brussel, GHA ;
Coutinho, RA ;
van Ameijden, EJC .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2001, 91 (05) :774-780
[25]   Needle exchange program attendance and injection risk in Providence, Rhode Island [J].
Longshore, D ;
Bluthenthal, RN ;
Stein, MD .
AIDS EDUCATION AND PREVENTION, 2001, 13 (01) :78-90
[26]  
Loxley W., 1998, International Journal of Drug Policy, V9, P255, DOI 10.1016/S0955-3959(98)00032-2
[27]   Seroprevalence of hepatitis C markers among intravenous drug users in western European countries:: a systematic review [J].
Matheï, C ;
Buntinx, F ;
Damme, PV .
JOURNAL OF VIRAL HEPATITIS, 2002, 9 (03) :157-173
[28]   HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway [J].
Miller, M ;
Mella, T ;
Moi, T ;
Eskild, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (03) :373-379
[29]   The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users [J].
Murray, JM ;
Law, MG ;
Gao, ZH ;
Kaldor, JM .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2003, 32 (05) :708-714
[30]  
MYERS T, 1995, PHARM COMMUNAUTAIRES